ASOs are short (14–20 nucleotides), synthetic, single-stranded oligodeoxynucleotides that can alter RNA and modify protein expression. Recent advances have been made to improve their potency, efficacy, stability, and pharmacokinetic properties.
Read the Full Article from GEN